{"altmetric_id":2413954,"counts":{"readers":{"mendeley":75,"citeulike":1,"connotea":1},"policy":{"unique_users_count":1,"unique_users":["gov_uk"],"posts_count":1},"total":{"posts_count":4},"wikipedia":{"unique_users_count":3,"unique_users":["en:185388","en:5393133","sv:619311"],"posts_count":3}},"citation":{"abstract":"This study assessed the efficacy of olanzapine in delaying or preventing conversion to psychosis and reducing symptoms in people with prodromal symptoms of schizophrenia.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e83cf058f610002216","authors":["McGlashan TH","Zipursky RB","Perkins D","Addington J","Miller T","Woods SW","Hawkins KA","Hoffman RE","Preda A","Epstein I","Addington D","Lindborg S","Trzaskoma Q","Tohen M","Breier A","Thomas McGlashan"],"doi":"10.1176\/appi.ajp.163.5.790","first_seen_on":"2014-06-09T01:37:42+00:00","issns":["0002-953X"],"issue":"5","journal":"American Journal of Psychiatry","last_mentioned_on":1303302597,"links":["http:\/\/dx.doi.org\/10.1176\/appi.ajp.163.5.790","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16648318","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16648318"],"pmid":"16648318","pubdate":"2006-05-02T00:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Psychology And Cognitive Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["psychiatry"],"title":"Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.","type":"article","uri":"http:\/\/psychiatryonline.org\/article.aspx?doi=10.1176\/appi.ajp.163.5.790","volume":"163","mendeley_url":"http:\/\/www.mendeley.com\/research\/randomized-doubleblind-trial-olanzapine-versus-placebo-patients-prodromally-symptomatic-psychosis-5"},"altmetric_score":{"score":6,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":6},"context_for_score":{"all":{"total_number_of_other_articles":8163518,"mean":6.8970466082141,"rank":1329285,"this_scored_higher_than_pct":82,"this_scored_higher_than":6748270,"rank_type":"exact","sample_size":8163518,"percentile":82},"similar_age_3m":{"total_number_of_other_articles":178940,"mean":7.3762625028644,"rank":31463,"this_scored_higher_than_pct":82,"this_scored_higher_than":147299,"rank_type":"exact","sample_size":178940,"percentile":82},"this_journal":{"total_number_of_other_articles":4895,"mean":11.114147118921,"rank":1284,"this_scored_higher_than_pct":69,"this_scored_higher_than":3421,"rank_type":"exact","sample_size":4895,"percentile":69},"similar_age_this_journal_3m":{"total_number_of_other_articles":29,"mean":38.959428571429,"rank":20,"this_scored_higher_than_pct":31,"this_scored_higher_than":9,"rank_type":"exact","sample_size":29,"percentile":31}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Student  > Doctoral Student":6,"Researcher":11,"Student  > Ph. D. Student":18,"Student  > Postgraduate":8,"Student  > Master":9,"Other":9,"Student  > Bachelor":2,"Lecturer":2,"Lecturer > Senior Lecturer":1,"Professor":2},"by_discipline":{"Medicine and Dentistry":25,"Neuroscience":8,"Psychology":26,"Agricultural and Biological Sciences":5,"Business, Management and Accounting":1,"Linguistics":1,"Unspecified":4}}},"geo":{"mendeley":{"AR":1,"HK":1,"US":2,"DK":1,"GB":1,"SI":1,"AU":1,"ES":1}}},"posts":{"wikipedia":[{"title":"Olanzapine","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=118888746#altmetric_citation_2","license":"public","citation_ids":[2413954],"posted_on":"2007-03-29T22:02:59+00:00","summary":"Olanzapine (sold under the brand names Zyprexa, Zypadhera and Lanzek or in combination with fluoxetine, Symbyax) is an atypical antipsychotic that belongs to thienobenzodiazepine class, approved by the U.S.","page_url":"http:\/\/en.wikipedia.org\/?curid=185388","wiki_lang":"en","author":{"name":"MastCell","url":"http:\/\/en.wikipedia.org\/wiki\/User:MastCell"}},{"title":"Thomas McGlashan","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=272046298#altmetric_citation_4","license":"public","citation_ids":[2413954],"posted_on":"2009-02-20T10:56:51+00:00","summary":"Dr. Thomas McGlashan (born 1942) is an American professor of psychiatry at Yale University, well known for his academic contributions to the study of schizophrenia and other mental illnesses.","page_url":"http:\/\/en.wikipedia.org\/?curid=5393133","wiki_lang":"en","author":{"name":"Earlypsychosis","url":"http:\/\/en.wikipedia.org\/wiki\/User:Earlypsychosis"}},{"title":"Olanzapin","url":"http:\/\/sv.wikipedia.org\/?diff=prev&oldid=4833236#altmetric_citation_5","license":"public","citation_ids":[2413954],"posted_on":"2007-08-22T02:02:03+00:00","summary":"Olanzapin (sld under flera namn som exempelvis Zyprexa, Zyprexa Velotab, Zypadhera (Zyprexa som depinjektion) eller i USA i kombination med fluoxetin, (Symbyax) r ett s kallat neuroleptikum, ett atypiskt antipsykotikum.","page_url":"http:\/\/sv.wikipedia.org\/?curid=619311","wiki_lang":"sv","author":{"name":"85.230.207.33","url":"http:\/\/sv.wikipedia.org\/wiki\/Special:Contributions\/85.230.207.33"}}],"policy":[{"title":"Download Mental health promotion and mental illness prevention: The economic case (updated April 2011)","url":"https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/215626\/dh_126386.pdf","license":"public","citation_ids":[447277,2818686,14725026,3204542,3217892,9647628,5727784,14579589,14947005,20462456,2197675,20462458,2228521,18111652,227929,5375380,15640369,1431724,5066599,3550717,180316,12577813,2432625,20462464,1131167,616655,3595755,2413954,2413935,821379,20462468,5754849,9706107,1057224,4259645,2412409,3751075,20462472,185924,104285,9971207],"posted_on":"2011-04-20T12:29:57+00:00","source":{"name":"UK Government (GOV.UK)","description":"GOV.UK is a central website that covers all UK government departments, as well as many other agencies and public bodies. All policy papers and research publications by the UK government are listed on GOV.UK.","geo":{"country":"GB"}},"page_url":"https:\/\/www.gov.uk\/government\/publications\/mental-health-promotion-and-mental-illness-prevention-the-economic-case","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-96cc30bd0455a42240f377af9afd4239257aa699fc29e32faea8668b953862e3.jpg"}}]}}